Spending on care: Aflac spends much more on member benefits and less on overhead than the average Medicare Supplement Insurance company. Complaints: Aflac members file complaints about their ...

Should Medicare and Medicaid eventually cover new weight loss drugs such as Ozempic and Wegovy? This week, Audacy took a look ...

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...

The Farina family was relieved when their matriarch, Gloria, qualified for Medicaid in 2023 after a grueling application process. The support allows Gloria, 91, to remain at her assisted-living ...

👋 Welcome to 5 Things PM! Hormonal birth control pills can be used to prevent pregnancy, and they’re also a popular way to go months or even years without a period. But is it safe? A ...

Trying to keep up with Medicare Part D changes can feel like a full-time job. Though the program is supposed to make life easier for enrollees, major changes in 2025 – including a new $2,000 out ...

3️⃣ Semaglutide crackdown: Shortages of Ozempic and other GLP-1 drugs for weight loss and diabetes allowed pharmacies to sell off-brand products not approved by the US Food and Drug ...

In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to ...

Wellabe, formerly Medico, offers solid discounts and low premiums in certain locations, but gets more customer complaints than average. Many, or all, of the products featured on this page are from ...

Modern Healthcare: UnitedHealth Group To Cut Medicare Drug Plan Commissions UnitedHealth Group plans to stop paying commissions next month to brokers and sales agents who sell new Medicare Part D ...

More than 68 million people rely on Medicare for their health coverage, including 55.5 million adults enrolled in prescription drug coverage under Medicare Part D. In 2023, Part D drug spending ...

UnitedHealth Group plans to stop paying commissions next month to brokers and sales agents who sell new Medicare Part D prescription drug plans. The insurer, which has had a rough week that's ...